Bradley A. Maron MD
Adjunct Instructor, Cardiovascular Medicine
Associate Professor, Medicine
72 E. Concord Street | (617) 638-5300bmaron@partners.org
Sections
Cardiovascular Medicine
Biography
Dr. Bradley Allen Maron is a cardiovascular medicine specialist at Brigham and Women’s Hospital (BWH) and an assistant professor of medicine at Harvard Medical School (HMS). In addition, he serves as a co-director of the Pulmonary Vascular Disease Center at VA Boston Healthcare System.
He received his medical degree from The Warren Alpert Medical School of Brown University and completed an internal medicine residency at Boston Medical Center. He then completed cardiovascular medicine research and clinical fellowship programs at BWH.
Other Positions
Websites
Education
Medicine, MD, Brown University
Psychology, BA, Williams College
Publications
Sklepinski SM, Deng Y, Swarna KS, Herrin J, Polley EC, Neumiller JJ, Galindo RJ, Umpierrez GE, Ross JS, Borah BJ, Maron BA, Mickelson MM, McCoy RG. Comparative effectiveness of GLP-1 receptor agonists on cardiovascular outcomes among adults with type 2 diabetes and moderate cardiovascular risk: emulation of a target trial. Diabetes Res Clin Pract. 2025 Sep 20; 229:112910. PMID: 40983112.
Published on 9/8/2025Zeder K, Mak S, Galie N, Rosenkranz S, Maron BA. Right heart catheterization in heart failure: indications, interpretation, and pitfalls. Eur Heart J. 2025 Sep 08; 46(34):3354-3372. PMID: 40521783.
Published on 8/27/2025Huang SJ, Robinson-Ector KS, Sehgal NJ, Golden SH, Davis EM, Ratzki-Leewing A, Chen C, Akintoye O, Roy DJ, Abaku O, Ding ML, Maron BA, McCoy RG. Persistent effects of historical redlining on present day hospital siting and size. Health Place. 2025 Sep; 95:103538. PMID: 40876381.
Published on 7/17/2025Deng Y, Polley EC, Herrin J, Swarna KS, Kent DM, Ross JS, Maron BA, Mickelson MM, McCoy RG. Heterogeneity of Cardiovascular Effects of Second-Line Glucose-Lowering Therapies in Adults With Type 2 Diabetes Across the Range of Moderate Baseline Cardiovascular Risk. J Am Heart Assoc. 2025 Aug 05; 14(15):e040217. PMID: 40673553.
Published on 7/12/2025Samokhin AO, Seo HS, Leed A, Hajian B, Bird GH, McKinney DC, Saha P, Daum J, Moroco JA, Yehl J, Kornfilt D, Szczeniowski A, Petrunak E, Horner S, Kalin JH, Leymarie N, Kaushik VK, Walensky LD, Cole PA, Oldham WM, Steinhauser ML, Dhe-Paganon S, Maron BA. Targeting NEDD9-SH3 with a Covalent Peptide Controls Endothelial Phenotype. bioRxiv. 2025 Jul 12. PMID: 40672237.
Published on 7/7/2025Maron BA. Precision medicine in pulmonary hypertension: how close are we today? Curr Opin Pulm Med. 2025 Sep 01; 31(5):429-436. PMID: 40620185.
Published on 7/1/2025Bordag N, Nagy BM, Zügner E, Ludwig H, Foris V, Nagaraj C, Biasin V, Kovacs G, Kneidinger N, Bodenhofer U, Magnes C, Maron BA, Ulrich S, Lange TJ, Eichmann TO, Hoetzenecker K, Pieber T, Olschewski H, Olschewski A. Lipid Ratios for Diagnosis and Prognosis of Pulmonary Hypertension. Am J Respir Crit Care Med. 2025 Jul; 211(7):1264-1276. PMID: 40343938.
Published on 6/1/2025Maron BA. Simplifying Sotatercept in Pulmonary Arterial Hypertension: Genetic Context Meets Treatment Response. Am J Respir Crit Care Med. 2025 Jun; 211(6):906-907. PMID: 40315138.
Published on 5/29/2025Maron BA. Sotatercept and the Clinical Transformation of Pulmonary Arterial Hypertension. N Engl J Med. 2025 May 29; 392(20):2059-2061. PMID: 40435469.
Published on 5/29/2025Zeder K, Kundu S, Siew ED, Annis JS, Lee LY, Garry J, Birdwell KA, Freiberg MS, Kovacs G, Brittain EL, Maron BA. Longitudinal Pulmonary Arterial Pressure Trajectories Inform Clinical Outcome in Kidney Transplantation Patients. Chest. 2025 May 29. PMID: 40449880.